
Researchers identify a modulator drug of the immune system to be potentially useful to block Parkinson’s disease
Parkinson’s disease is one of the most common diseases affecting the motor and the nervous system. It has no treatment yet, and this pathology causes a deterioration of the motor skills due to dopaminergic neuronal death, the neurons that synthetize dopamine, a brain neurotransmitter that controls the volunteer movements. Now, a study on Parkinson’s published







